Proteins That Cause Blood Vessel Damage In Preeclampsia Identified by Researchers
Main Category: Pregnancy / ObstetricsAlso Included In: Hypertension
Article Date: 21 Mar 2007 - 8:00 PDT
|
|
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
1 (1 votes) |
Proteins released by the placenta may damage blood vessels in women with preeclampsia (PE), according to an abstract presented by Yale School of Medicine researchers at the Society for Gynecologic Investigation Conference in Reno, Nevada.
In PE, a complication of pregnancy linked to life-threatening increases in high blood pressure after 20 weeks of gestation, it has long been recognized that substances called "microparticles" released by the placenta damage maternal blood vessels. Researchers at Yale, led by Seth Guller, sought to detect whether specific proteins were found in microparticles.
The team, including researchers from Berne, Switzerland, studied placentas obtained from patients with preeclampsia who had uncomplicated pregnancies delivered at term by cesarean section. They found that microparticles released from the placenta contain a protein that regulates clot formation (plasminogen activator inhibitor-1). They also found that microparticles contain soluble Flt-1, which inhibits blood vessel growth, and that microparticles contain extremely high levels of plasminogen activator inhibitor-2, a placental protein with no known function.
"In this study, we demonstrate for the first time that microparticles released by the placenta may contain factors that damage maternal blood vessels in preeclampsia," said Guller, associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences.
Guller said for this study, the team only detected whether specific proteins were found in microparticles. "In the future, we will determine whether they are biologically active - promote damage in vessel culture models - and whether they are present in the blood of women with preeclampsia," said Guller.
###
Other authors on the abstract included Yuehong Ma, Stefano Di Santo, Graciela Krikun, Antoine Malek and Henning Schneider.
Abstract #574: "Microparticles (MPs) Shed from Human Placenta Contain Anti-Fibinolytic and Anti-Angiogenic Compounds: Complications in Preeclampsia."
Contact: Karen N. Peart
Yale University
Visit our pregnancy / obstetrics section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/65516.php>
APA
http://www.medicalnewstoday.com/releases/65516.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




